Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elliott, J. L.
Right arrow Articles by Pestronk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elliott, J. L.
Right arrow Articles by Pestronk, A.
NEUROLOGY 1994;44:967
© 1994 American Academy of Neurology

Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin

Jeffrey L. Elliott, MD and Alan Pestronk, MD

Department of Neurology, Washington University School of Medicine, St. Louis, MO.

Article abstract We report a patient with multifocal motor neuropathy (MMN) who experienced a paradoxical decline in baseline strength to below pretreatment levels during a period of improvement associated with human immunoglobulin (HIG) administration. This outcome suggests that HIG may not limit progression of MMN and may reduce the utility of HIG as chronic therapy.

Address correspondence and reprint requests to Dr. Alan Pestronk, Department of Neurology, Box 811 1, Washington University School of Medicine. 660 S. Euclid Avenue, St. Louis, MO 63110.

Received October 11, 1993. Accepted for publication i n final form November 9, 1993.




This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A Pestronk, J Florence, T Miller, R Choksi, M T Al-Lozi, and T D Levine
Treatment of IgM antibody associated polyneuropathies using rituximab
J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 485 - 489.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. L. Koski
Therapy of CIDP and related immune-mediated neuropathies
Neurology, December 24, 2002; 59(90126): S22 - 27.
[Abstract] [Full Text]

Home page
 BrainHome page
R. M. Van den Berg-Vos, H. Franssen, J. H. J. Wokke, and L. H. V. d. Berg
Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment
Brain, August 1, 2002; 125(8): 1875 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
D. Karussis and O. Abramsky
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?: No
Arch Neurol, August 1, 1999; 56(8): 1028 - 1032.
[Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A Lagueny, G Le Masson, P Burbeaud, and P. Deliac
Single fibre electromyography in multifocal motor neuropathy with persistent conduction blocks
J. Neurol. Neurosurg. Psychiatry, September 1, 1998; 65(3): 357 - 361.
[Abstract] [Full Text]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
N. Meucci, A. Cappellari, S. Barbieri, G. Scarlato, and E. Nobile-Orazio
Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy
J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 765 - 769.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.